Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy

NCT02332447 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

485

Enrollment

OTHER

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: naloxone
DRUG: Placebo

Sponsor

Hospices Civils de Lyon